why is it difficult to develop vaccine against schistosoma?

Developing a vaccine against Schistosoma is difficult mainly because the parasite is much more complex than viruses or bacteria. Schistosomes go through several stages during their life cycle, and each stage can have different proteins that the immune system sees. This makes it difficult to identify one vaccine target that produces strong and lasting protection. Another challenge is that the parasite has evolved ways to avoid or modify the human immune response. People living in areas where schistosomiasis is common may also have been exposed to the parasite multiple times or have other infections, which can affect how their immune system responds to a vaccine. Researchers also face difficulties predicting whether a vaccine that works well in laboratory animals will provide similar protection in humans. There is still no universally accepted marker that reliably indicates protection against schistosomiasis. There is currently no licensed human vaccine for schistosomiasis, although several vaccine candidates are being studied. In simple terms, the main problem is that Schistosoma has a complicated life cycle, can evade the immune system, and produces different immune responses at different stages, making it challenging to develop a vaccine that is both safe and consistently effective. Visi:- https://www.onlinegenericmedicine.com